100 related articles for article (PubMed ID: 8611517)
1. Dimerization of the human cytomegalovirus protease: kinetic and biochemical characterization of the catalytic homodimer.
Margosiak SA; Vanderpool DL; Sisson W; Pinko C; Kan CC
Biochemistry; 1996 Apr; 35(16):5300-7. PubMed ID: 8611517
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the induced-fit mechanism and catalytic activity of the human cytomegalovirus protease homodimer via molecular dynamics simulations.
de Oliveira CA; Guimarães CR; Barreiro G; de Alencastro RB
Proteins; 2003 Sep; 52(4):483-91. PubMed ID: 12910449
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism for dimerization to regulate the catalytic activity of human cytomegalovirus protease.
Batra R; Khayat R; Tong L
Nat Struct Biol; 2001 Sep; 8(9):810-7. PubMed ID: 11524687
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional structure of human cytomegalovirus protease.
Shieh HS; Kurumbail RG; Stevens AM; Stegeman RA; Sturman EJ; Pak JY; Wittwer AJ; Palmier MO; Wiegand RC; Holwerda BC; Stallings WC
Nature; 1996 Sep; 383(6597):279-82. PubMed ID: 8805708
[TBL] [Abstract][Full Text] [Related]
5. Activity in monomers of human cytomegalovirus protease.
Holwerda B
Biochem Biophys Res Commun; 1999 Jun; 259(2):370-3. PubMed ID: 10362516
[TBL] [Abstract][Full Text] [Related]
6. Characterization of human cytomegalovirus protease dimerization by analytical centrifugation.
Cole JL
Biochemistry; 1996 Dec; 35(48):15601-10. PubMed ID: 8952514
[TBL] [Abstract][Full Text] [Related]
7. Active human cytomegalovirus protease is a dimer.
Darke PL; Cole JL; Waxman L; Hall DL; Sardana MK; Kuo LC
J Biol Chem; 1996 Mar; 271(13):7445-9. PubMed ID: 8631772
[TBL] [Abstract][Full Text] [Related]
8. Site-directed mutagenesis probing the catalytic role of arginines 165 and 166 of human cytomegalovirus protease.
Liang PH; Brun KA; Feild JA; O'Donnell K; Doyle ML; Green SM; Baker AE; Blackburn MN; Abdel-Meguid SS
Biochemistry; 1998 Apr; 37(17):5923-9. PubMed ID: 9558326
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the monomer-dimer equilibrium of human cytomegalovirus protease by kinetic methods.
Khayat R; Batra R; Bebernitz GA; Olson MW; Tong L
Biochemistry; 2004 Jan; 43(2):316-22. PubMed ID: 14717585
[TBL] [Abstract][Full Text] [Related]
10. A new serine-protease fold revealed by the crystal structure of human cytomegalovirus protease.
Tong L; Qian C; Massariol MJ; Bonneau PR; Cordingley MG; Lagacé L
Nature; 1996 Sep; 383(6597):272-5. PubMed ID: 8805706
[TBL] [Abstract][Full Text] [Related]
11. Unique fold and active site in cytomegalovirus protease.
Qiu X; Culp JS; DiLella AG; Hellmig B; Hoog SS; Janson CA; Smith WW; Abdel-Meguid SS
Nature; 1996 Sep; 383(6597):275-9. PubMed ID: 8805707
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and molecular characterization of a detergent-stable serine alkaline protease from Bacillus pumilus CBS with high catalytic efficiency.
Jaouadi B; Ellouz-Chaabouni S; Rhimi M; Bejar S
Biochimie; 2008 Sep; 90(9):1291-305. PubMed ID: 18397761
[TBL] [Abstract][Full Text] [Related]
13. The herpesvirus protease: mechanistic studies and discovery of inhibitors of the human cytomegalovirus protease.
Flynn DL; Becker DP; Dilworth VM; Highkin MK; Hippenmeyer PJ; Houseman KA; Levine LM; Li M; Moormann AE; Rankin A; Toth MV; Villamil CI; Wittwer AJ; Holwerda BC
Drug Des Discov; 1997 May; 15(1):3-15. PubMed ID: 9332827
[TBL] [Abstract][Full Text] [Related]
14. Structure and assembly of the catalytic region of human complement protease C1r: a three-dimensional model based on chemical cross-linking and homology modeling.
Lacroix M; Rossi V; Gaboriaud C; Chevallier S; Jaquinod M; Thielens NM; Gagnon J; Arlaud GJ
Biochemistry; 1997 May; 36(21):6270-82. PubMed ID: 9174342
[TBL] [Abstract][Full Text] [Related]
15. Human cytomegalovirus maturational proteinase: expression in Escherichia coli, purification, and enzymatic characterization by using peptide substrate mimics of natural cleavage sites.
Burck PJ; Berg DH; Luk TP; Sassmannshausen LM; Wakulchik M; Smith DP; Hsiung HM; Becker GW; Gibson W; Villarreal EC
J Virol; 1994 May; 68(5):2937-46. PubMed ID: 8151764
[TBL] [Abstract][Full Text] [Related]
16. Functional determinants of the Epstein-Barr virus protease.
Buisson M; Valette E; Hernandez JF; Baudin F; Ebel C; Morand P; Seigneurin JM; Arlaud GJ; Ruigrok RW
J Mol Biol; 2001 Aug; 311(1):217-28. PubMed ID: 11469870
[TBL] [Abstract][Full Text] [Related]
17. Single-chain recombinant human cytomegalovirus protease. Activity against its natural protein substrate and fluorogenic peptide substrates.
Pinko C; Margosiak SA; Vanderpool D; Gutowski JC; Condon B; Kan CC
J Biol Chem; 1995 Oct; 270(40):23634-40. PubMed ID: 7559530
[TBL] [Abstract][Full Text] [Related]
18. Human cytomegalovirus protease complexes its substrate recognition sequences in an extended peptide conformation.
LaPlante SR; Aubry N; Bonneau PR; Cameron DR; Lagacé L; Massariol MJ; Montpetit H; Plouffe C; Kawai SH; Fulton BD; Chen Z; Ni F
Biochemistry; 1998 Jul; 37(27):9793-801. PubMed ID: 9657693
[TBL] [Abstract][Full Text] [Related]
19. Solution structure of the catalytic domain of gammadelta resolvase. Implications for the mechanism of catalysis.
Pan B; Maciejewski MW; Marintchev A; Mullen GP
J Mol Biol; 2001 Jul; 310(5):1089-107. PubMed ID: 11501998
[TBL] [Abstract][Full Text] [Related]
20. Kinetics, inhibition and oligomerization of Epstein-Barr virus protease.
Buisson M; Rivail L; Hernandez JF; Jamin M; Martinez J; Ruigrok RW; Burmeister WP
FEBS Lett; 2006 Dec; 580(28-29):6570-8. PubMed ID: 17118362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
